Sufficient and Persistent Blood Pressure Reduction in the Final Long-Term Results From SYMPLICITY HTN-Japan　― Safety and Efficacy of Renal Denervation at 3 Years ―-Reference-Cited by-同舟云学术

Sufficient and Persistent Blood Pressure Reduction in the Final Long-Term Results From SYMPLICITY HTN-Japan　― Safety and Efficacy of Renal Denervation at 3 Years ―

Published:2019-02-25 Issue:3 Volume:83 Page:622-629
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Kario Kazuomi¹,Yamamoto Eiichiro²,Tomita Hirofumi³,Okura Takafumi⁴,Saito Shigeru⁵,Ueno Takafumi⁶,Yasuhara Daiki⁷,Shimada Kazuyuki⁸,

Affiliation:

1. Division of Cardiovascular Medicine, Jichi Medical University School of Medicine

2. Kumamoto University Hospital

3. Hirosaki University School of Medicine and Hospital

4. Ehime University Hospital

5. Shonan Kamakura General Hospital

6. Kurume University Hospital

7. Medtronic Japan

8. New Oyama Municipal Hospital

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/83/3/83_CJ-18-1018/_pdf

Reference32 articles.

1. 1. Miura K, Nagai M, Ohkubo T. Epidemiology of hypertension in Japan: Where are we now? Circ J 2013; 77: 2226–2231.

2. 2. Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res 2009; 32: 3–107.

3. 3. Kario K, Okura A, Okawara Y, Tomitani N, Ikemoto T, Hoshide S. Impact of introducing catheter-based renal denervation into Japan for hypertension management: Estimation of number of target patients and clinical relevance of ambulatory blood pressure reduction. Curr Hypertens Rev 2016; 12: 156–163.

4. 4. Esler MD, Bohm M, Sievert H, Rump CL, Schmieder RE, Krum H, et al. Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial. Eur Heart J 2014; 35: 1752–1759.

5. 5. Krum H, Schlaich MP, Sobotka PA, Bohm M, Mahfoud F, Rocha-Singh K, et al. Percutaneous renal denervation in patients with treatment-resistant hypertension: Final 3-year report of the Symplicity HTN-1 study. Lancet 2014; 383: 622–629.

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Renal denervation benefits in chronic kidney disease: An updated review;Yemen Journal of Medicine;2024-09-15

2. What are the ideal metrics for assessing the quality of long-term stabilized “perfect” 24-h BP control after renal denervation?;Hypertension Research;2024-08-28

3. Consensus statement on renal denervation by the Joint Committee of Japanese Society of Hypertension (JSH), Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT), and the Japanese Circulation Society (JCS);Cardiovascular Intervention and Therapeutics;2024-07-30

4. Consensus statement on renal denervation by the Joint Committee of Japanese Society of Hypertension (JSH), Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT), and the Japanese Circulation Society (JCS);Hypertension Research;2024-07-26

5. Consensus Statement on Renal Denervation by the Joint Committee of Japanese Society of Hypertension (JSH), Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT), and the Japanese Circulation Society (JCS);Circulation Journal;2024-07-26